KMS Medisurgi Limited FY2026 Results

KMS Medisurgi FY2026 Revenue: ₹12.21 crore
KMS Medisurgi FY2026 Net Profit: ₹0.25 crore

Reader Takeaway: Declining profits and qualified audit remarks overshadow the latest financial results, demanding investor vigilance.

What just happened

KMS Medisurgi Limited announced its audited financial results for the year ended March 31, 2026. The company reported a revenue from operations of ₹12.21 crore, a decrease of 12.4% compared to ₹13.94 crore in FY2025. Net profit saw a sharper decline of 44.2%, falling to ₹0.25 crore from ₹0.44 crore in the previous fiscal year. Earnings per share (EPS) also decreased to ₹0.74 from ₹1.33.

Why this matters

The decline in both revenue and net profit indicates potential headwinds for the company. The steeper fall in profitability suggests pressure on margins. Additionally, the qualified opinion from auditors raises concerns about financial reporting and internal controls, which could impact investor confidence.

The backstory

In FY2025, KMS Medisurgi had reported revenues of ₹13.94 crore and a net profit of ₹0.44 crore. The current year's results show a reversal of this trend, with a notable decrease across key financial metrics.

What changes now

Investors will be closely watching for improvements in the company's financial performance in the upcoming quarters. The focus will also be on how the company addresses the auditors' qualifications, particularly regarding inventory reconciliation and employee benefit accounting.

Risks to watch

The repetitive nature of the audit qualifications on inventory and employee benefits is a significant risk. Failure to resolve these issues could lead to further scrutiny and potentially impact future financial reporting accuracy. The declining profitability also poses a risk to sustained growth.

Peer comparison

[Peer comparison data not available in the filing.]

Context metrics

As of March 31, 2026, KMS Medisurgi's total assets stood at ₹10.55 crore and total liabilities at ₹2.23 crore.

What to track next

Investors should monitor upcoming quarterly results for signs of financial recovery. Crucially, updates on the inventory reconciliation process and any steps taken to align with accounting standards for employee benefits will be key indicators.